NO955274L - Fremgangsmåte og anordning for forsegling av implanterbare membraninnkapslingsanordninger - Google Patents

Fremgangsmåte og anordning for forsegling av implanterbare membraninnkapslingsanordninger

Info

Publication number
NO955274L
NO955274L NO955274A NO955274A NO955274L NO 955274 L NO955274 L NO 955274L NO 955274 A NO955274 A NO 955274A NO 955274 A NO955274 A NO 955274A NO 955274 L NO955274 L NO 955274L
Authority
NO
Norway
Prior art keywords
individual
coupling
sealing
cavity
tight
Prior art date
Application number
NO955274A
Other languages
English (en)
Other versions
NO955274D0 (no
Inventor
John F Mills
Edward J Doherty
Tyrone F Hazlett
Keith E Dionne
Nicholas F Warner
Brian M Cain
David H Rein
Original Assignee
Univ Brown Res Found
Cytotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Brown Res Found, Cytotherapeutics Inc filed Critical Univ Brown Res Found
Publication of NO955274D0 publication Critical patent/NO955274D0/no
Publication of NO955274L publication Critical patent/NO955274L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Prostheses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Encapsulation Of And Coatings For Semiconductor Or Solid State Devices (AREA)

Abstract

Det er beskrevet en forseglet Implanterbar Innkaps- llngsanordnlng (20) for å tilføre et biologisk aktivt produkt eller funksjon til et Individ som Innbefatter en i det vesentlige Ikke-porøs kopling (32) med en Indre overflate (33) som definerer en Innløpsåpnlng (34). Et permselektlvt porøst membran (21) med en, Indre overflate (22) samvirker med koplingens Indre overflate (33) og danner et lagrlngshulrom (23) mellom | disse. Membranets Indre overflate (22) er l l det j vesentlige celle-tett, tørt, tettende Inngrep med ! koplingen (32) for å forsegle hulrommet (23). Levende celler (24) er anbragt l hulrommet (23) som kan i utsondre det biologisk aktive produktet til et Individ, i Membranet (21) er av et materiale som er Istand til å tillate passering av substanser mellom Individet og cellene som er nødvendig for å tilveiebringe det biologiske produktet eller funksjonen. Et plugglegeme (35) er anbragt i Innløpsåpnlngen (34), og er ansatt l celle-tett, tettende Inngrep med koplingens Indre overflate (33). Det er også tllvelebragt en fremgangs- måte for forsegling av den Implantere Innkapslingsan- ordnlngen (20).
NO955274A 1993-06-23 1995-12-22 Fremgangsmåte og anordning for forsegling av implanterbare membraninnkapslingsanordninger NO955274L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8240793A 1993-06-23 1993-06-23
PCT/US1994/007015 WO1995001203A2 (en) 1993-06-23 1994-06-22 Implantable membrane encapsulation apparatus

Publications (2)

Publication Number Publication Date
NO955274D0 NO955274D0 (no) 1995-12-22
NO955274L true NO955274L (no) 1996-02-15

Family

ID=22171016

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955274A NO955274L (no) 1993-06-23 1995-12-22 Fremgangsmåte og anordning for forsegling av implanterbare membraninnkapslingsanordninger

Country Status (11)

Country Link
US (6) US5713887A (no)
EP (1) EP0708670A4 (no)
JP (1) JPH09502620A (no)
KR (1) KR960703343A (no)
CN (1) CN1129402A (no)
AU (1) AU688776B2 (no)
CA (1) CA2166116A1 (no)
FI (1) FI956218A7 (no)
NO (1) NO955274L (no)
NZ (1) NZ269041A (no)
WO (1) WO1995001203A2 (no)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5550050A (en) 1994-04-15 1996-08-27 Cytotherapeutics, Inc. Method for implanting encapsulated cells in a host
US5935849A (en) 1994-07-20 1999-08-10 Cytotherapeutics, Inc. Methods and compositions of growth control for cells encapsulated within bioartificial organs
US5681740A (en) * 1995-06-05 1997-10-28 Cytotherapeutics, Inc. Apparatus and method for storage and transporation of bioartificial organs
WO1997010807A1 (en) * 1995-09-22 1997-03-27 Gore Hybrid Technologies, Inc. Improved cell encapsulation device
US6283951B1 (en) 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
US5964261A (en) * 1996-05-29 1999-10-12 Baxter International Inc. Implantation assembly
US5976780A (en) * 1996-07-16 1999-11-02 Shah; Kumarpal A. Encapsulated cell device
US6054142A (en) * 1996-08-01 2000-04-25 Cyto Therapeutics, Inc. Biocompatible devices with foam scaffolds
US6066254A (en) * 1996-10-10 2000-05-23 The Dow Chemical Company Fluid filter assemblies with integral fluid seals
MY125849A (en) * 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems
US6042909A (en) * 1997-09-03 2000-03-28 Circe Biomedical, Inc. Encapsulation device
US6206914B1 (en) * 1998-04-30 2001-03-27 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
DE19831699C1 (de) * 1998-07-15 2000-04-27 Caremed Medical Produkte Ag Implantathalter
US6903244B1 (en) 1999-02-26 2005-06-07 University Of Utah Research Foundation Mice which are +/− or −/− for the elastin gene as models for vascular disease
US6303355B1 (en) 1999-03-22 2001-10-16 Duke University Method of culturing, cryopreserving and encapsulating pancreatic islet cells
US6365385B1 (en) 1999-03-22 2002-04-02 Duke University Methods of culturing and encapsulating pancreatic islet cells
US20070071734A1 (en) * 1999-04-06 2007-03-29 Weng Tao ARPE-19 as platform cell line for encapsulated cell-based delivery
US6361771B1 (en) 1999-04-06 2002-03-26 Neurotech S.A. ARPE-19 as a platform cell line for encapsulated cell-based delivery
US6982058B2 (en) * 1999-12-08 2006-01-03 Baxter International, Inc. Method for fabricating three dimensional structures
US20030168396A1 (en) * 1999-12-08 2003-09-11 Jacobson James D. Monolithic filter body and fabrication technique
US6520997B1 (en) 1999-12-08 2003-02-18 Baxter International Inc. Porous three dimensional structure
ATE354430T1 (de) 1999-12-08 2007-03-15 Baxter Int Verfahren zur herstellung einer mikroporösen filtermembran
US6450937B1 (en) * 1999-12-17 2002-09-17 C. R. Bard, Inc. Needle for implanting brachytherapy seeds
US6284531B1 (en) * 2000-01-12 2001-09-04 Hong Zhu Multi-compartment device for cultivating microorganisms
US6617151B1 (en) * 2000-02-29 2003-09-09 Gore Enterprise Holdings, Inc. Method of closing a cell containment device with a wet seal
US7521019B2 (en) * 2001-04-11 2009-04-21 Lifescan, Inc. Sensor device and methods for manufacture
US20030213007A1 (en) * 2002-03-27 2003-11-13 Slattery Charles Wilbur Human milk produced by human mammary tissue implanted in non-human host animals and uses thereof
US7025982B2 (en) * 2002-09-19 2006-04-11 Medtronic, Inc. Medical assembly suitable for long-term implantation and method for fabricating the same
AU2002952993A0 (en) 2002-11-29 2002-12-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic and diagnostic agents
NZ544263A (en) 2003-06-10 2009-04-30 Nsgene As Improved secretion of neublastin
EP1667516A4 (en) 2003-08-29 2009-11-11 Inst Medical W & E Hall METHOD FOR SELECTION OF ANIMAL MODELS FROM ANIMALS MUTAGENICALLY SUBJECTED AND THE USE OF MYB TRANSCRIPTION FACTORS FOR SCREENING
IL157981A (en) 2003-09-17 2014-01-30 Elcam Medical Agricultural Cooperative Ass Ltd Auto injector
BRPI0415563A (pt) 2003-10-20 2007-01-02 Nsgene As método para o tratamento do mal de parkinson, uso de um vetor viral, vetor de expressão viral, composição farmacêutica, célula hospedeira isolada, linhagem de células de empacotamento, mamìfero não humano quimérico, dispositivo de cultura celular implantável, cápsula biocompatìvel, método para tratamento de uma doença do sistema nervoso, célula de mamìfero, e, método para produzir neurturin ou um seu equivalente funcional
EP1701736A4 (en) 2003-12-24 2008-05-07 Inst Medical W & E Hall THERAPEUTIC AGENTS AND USES
US20080286323A1 (en) * 2004-01-19 2008-11-20 Nsgene A/S Human Therapeutic Cells Secreting Nerve Growth Factor
IL160891A0 (en) 2004-03-16 2004-08-31 Auto-mix needle
AU2005229434B2 (en) 2004-03-30 2010-09-30 Nsgene A/S Therapeutic use of a growth factor, NsG33
WO2005108981A1 (en) 2004-05-12 2005-11-17 The Walter And Eliza Hall Institute Of Medical Research A method of cell isolation
WO2006013462A2 (en) * 2004-07-30 2006-02-09 Nsgene A/S Growth factors nsg28, nsg30, and nsg32
JP2008533995A (ja) * 2005-04-01 2008-08-28 エヌエスジーン・アクティーゼルスカブ ヒト不死化神経前駆細胞系
EP1883446B8 (en) * 2005-05-17 2017-11-15 Gloria Therapeutics Sarl An implantable therapy system for treating a living being with an active factor
AU2006261599B2 (en) 2005-06-24 2011-10-06 The Walter & Eliza Hall Institute Of Medical Research Therapeutic pro-apoptotic BH3-like molecules and methods for generating and/or selecting the same
EP1940471A1 (en) * 2005-10-28 2008-07-09 NsGene A/S IMPLANTABLE BIOCOMPATIBLE IMMtTNOISOLATORY VEHICLE FOR DELIVERY OF GDNF
CA2635534C (en) * 2005-12-30 2014-07-29 Neurotech Usa Inc. Micronized device for the delivery of biologically active molecules and methods of use thereof
AU2007275764B2 (en) 2006-07-18 2013-11-14 University Of Utah Research Foundation Methods for treating pain and screening analgesic compounds
US8361489B2 (en) * 2006-08-29 2013-01-29 The University Of Akron Implantable devices for producing insulin
CA2698212A1 (en) 2007-08-23 2009-02-26 Intrexon Corporation Methods and compositions for diagnosing disease
US8093038B2 (en) * 2007-09-17 2012-01-10 Illinois Institute Of Technology Apparatus and method for encapsulating pancreatic cells
MX2010003371A (es) 2007-09-28 2010-05-05 Intrexon Corp Constructos interruptores genicos terapeuticos y biorreactores para la expresion de moleculas bioterapeuticas y usos de los mismos.
US8211134B2 (en) * 2007-09-29 2012-07-03 Restoration Robotics, Inc. Systems and methods for harvesting, storing, and implanting hair grafts
US9023063B2 (en) 2008-04-17 2015-05-05 Apollo Endosurgery, Inc. Implantable access port device having a safety cap
US9023062B2 (en) 2008-04-17 2015-05-05 Apollo Endosurgery, Inc. Implantable access port device and attachment system
JP2012508584A (ja) * 2008-11-14 2012-04-12 ヴィアサイト,インコーポレイテッド ヒト多能性幹細胞由来膵臓細胞のカプセル化
AU2010206374B2 (en) 2009-01-23 2013-01-17 Gloriana Therapeutics Sarl Improved cell lines and their use in encapsulated cell biodelivery
EP2389191A2 (en) 2009-01-23 2011-11-30 NsGene A/S Expression of neuropeptides in mammalian cells
JP2012524544A (ja) * 2009-04-23 2012-10-18 ニューロテック ユーエスエー, インコーポレイテッド プロスタグランジンF2アルファ(PGF2a)を産生する細胞系およびその使用
US8715158B2 (en) 2009-08-26 2014-05-06 Apollo Endosurgery, Inc. Implantable bottom exit port
US8708979B2 (en) 2009-08-26 2014-04-29 Apollo Endosurgery, Inc. Implantable coupling device
US8506532B2 (en) 2009-08-26 2013-08-13 Allergan, Inc. System including access port and applicator tool
PL2470228T3 (pl) 2009-08-28 2018-03-30 Sernova Corporation Sposoby i urządzenia do przeszczepiania komórek
JP2013507373A (ja) * 2009-10-08 2013-03-04 ニューロテック ユーエスエー, インコーポレイテッド 被包された細胞ベースの送達系におけるpedfの使用
US8882728B2 (en) 2010-02-10 2014-11-11 Apollo Endosurgery, Inc. Implantable injection port
US20110270025A1 (en) 2010-04-30 2011-11-03 Allergan, Inc. Remotely powered remotely adjustable gastric band system
US8992415B2 (en) 2010-04-30 2015-03-31 Apollo Endosurgery, Inc. Implantable device to protect tubing from puncture
US20110270021A1 (en) 2010-04-30 2011-11-03 Allergan, Inc. Electronically enhanced access port for a fluid filled implant
US20120041258A1 (en) 2010-08-16 2012-02-16 Allergan, Inc. Implantable access port system
US20120065460A1 (en) 2010-09-14 2012-03-15 Greg Nitka Implantable access port system
CN103228229B (zh) 2010-09-27 2015-11-25 Ns基因公司 具有支持和径向扩散支架的可植入细胞装置
WO2012041328A1 (en) 2010-10-01 2012-04-05 Nsgene A/S Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
JP2014506119A (ja) 2010-12-02 2014-03-13 ニューロテック ユーエスエー, インコーポレイテッド 抗血管新生抗体足場および可溶性受容体を分泌する細胞株およびその使用
US8821373B2 (en) 2011-05-10 2014-09-02 Apollo Endosurgery, Inc. Directionless (orientation independent) needle injection port
US8801597B2 (en) 2011-08-25 2014-08-12 Apollo Endosurgery, Inc. Implantable access port with mesh attachment rivets
US9199069B2 (en) 2011-10-20 2015-12-01 Apollo Endosurgery, Inc. Implantable injection port
US8858421B2 (en) 2011-11-15 2014-10-14 Apollo Endosurgery, Inc. Interior needle stick guard stems for tubes
US9089395B2 (en) 2011-11-16 2015-07-28 Appolo Endosurgery, Inc. Pre-loaded septum for use with an access port
CN104640579A (zh) 2012-05-30 2015-05-20 神经技术美国有限公司 冷冻保存的可植入细胞培养装置及其用途
US9304028B2 (en) * 2012-09-20 2016-04-05 Nordson Corporation Adhesive dispensing device having optimized reservoir and capacitive level sensor
USD720469S1 (en) 2013-03-07 2014-12-30 Viacyte, Inc. Cell encapsulation device
AU2014225352B2 (en) 2013-03-07 2017-02-09 Viacyte, Inc. 3-dimensional large capacity cell encapsulation device assembly
JP6681826B2 (ja) 2013-05-31 2020-04-15 ザ ユニバーシティ オブ ユタ リサーチ ファウンデイション コノトキシンペプチド、医薬組成物およびそれらの使用
CA2922483A1 (en) 2013-09-11 2015-03-19 Neurotech Usa, Inc. Encapsulated cell therapy cartridge
CA2986769A1 (en) 2015-05-27 2016-12-01 Neurotech Usa, Inc. Use of encapsulated cell therapy for treatment of ophthalmic disorders
JP6877419B2 (ja) 2015-10-27 2021-05-26 ザ ユニバーシティー オブ クイーンズランド 治療の方法およびそのために有用な剤
CA3042495A1 (en) 2016-11-10 2018-05-17 Viacyte, Inc. Pdx1 pancreatic endoderm cells in cell delivery devices and methods thereof
CN112770697B (zh) * 2018-09-26 2024-05-14 W.L.戈尔及同仁股份有限公司 具有可控细胞床厚度的细胞封装设备
CN109507182B (zh) * 2018-12-04 2021-07-30 中山市中能检测中心有限公司 一种土壤酸碱度失衡检测装备及其使用方法
ES3051360T3 (en) * 2019-11-01 2025-12-26 Neurotech Usa Inc Analyte diffusive implantable device
WO2022011081A1 (en) 2020-07-09 2022-01-13 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Cell lines that produce human retinoschisin proteins and uses thereof
US20250152324A1 (en) 2022-02-25 2025-05-15 Viacyte, Inc. Multilayer implantable cell encapsulation devices and methods thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3615024A (en) * 1968-08-26 1971-10-26 Amicon Corp High flow membrane
US3919724A (en) * 1974-06-07 1975-11-18 Medical Eng Corp Implantable prosthesis having a self-sealing valve
US3987790A (en) * 1975-10-01 1976-10-26 Alza Corporation Osmotically driven fluid dispenser
US4352883A (en) * 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4352833A (en) * 1979-12-12 1982-10-05 Young, Prussin, Mgk, J.V. Adherent controlled release pesticides
US4294891A (en) * 1980-03-12 1981-10-13 The Montefiore Hospital Association Of Western Pennsylvania Intermittently refuelable implantable bio-oxidant fuel cell
DE3016906A1 (de) * 1980-05-02 1981-11-05 Henkel KGaA, 4000 Düsseldorf Neue kupplerkomponenten fuer oxidationshaarfarben, deren herstellung und verwendung, sowie diese enthaltende haarfaerbemittel
US4353888A (en) * 1980-12-23 1982-10-12 Sefton Michael V Encapsulation of live animal cells
US4378016A (en) * 1981-07-15 1983-03-29 Biotek, Inc. Artificial endocrine gland containing hormone-producing cells
US4402694A (en) * 1981-07-16 1983-09-06 Biotek, Inc. Body cavity access device containing a hormone source
GB8500121D0 (en) * 1985-01-03 1985-02-13 Connaught Lab Microencapsulation of living cells
US4892538A (en) * 1987-11-17 1990-01-09 Brown University Research Foundation In vivo delivery of neurotransmitters by implanted, encapsulated cells
US5182111A (en) * 1987-11-17 1993-01-26 Boston University Research Foundation In vivo delivery of active factors by co-cultured cell implants
US5158881A (en) * 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
US5487739A (en) * 1987-11-17 1996-01-30 Brown University Research Foundation Implantable therapy systems and methods
CA1294843C (en) * 1988-04-07 1992-01-28 Paul Y. Wang Implant for percutaneous sampling of serous fluid and for delivering drug upon external compression
US4976966A (en) * 1988-12-29 1990-12-11 Alza Corporation Delayed release osmotically driven fluid dispenser
WO1993000063A1 (en) * 1991-06-28 1993-01-07 Brown University Research Foundation Capsule extrusion systems

Also Published As

Publication number Publication date
NZ269041A (en) 1998-02-26
WO1995001203A3 (en) 1995-02-16
US6123700A (en) 2000-09-26
EP0708670A4 (en) 1998-07-01
WO1995001203A2 (en) 1995-01-12
NO955274D0 (no) 1995-12-22
US5653688A (en) 1997-08-05
AU7249094A (en) 1995-01-24
JPH09502620A (ja) 1997-03-18
CA2166116A1 (en) 1995-01-12
EP0708670A1 (en) 1996-05-01
AU688776B2 (en) 1998-03-19
US5713887A (en) 1998-02-03
CN1129402A (zh) 1996-08-21
FI956218A7 (fi) 1996-02-22
US5738673A (en) 1998-04-14
US5653687A (en) 1997-08-05
FI956218A0 (fi) 1995-12-22
KR960703343A (ko) 1996-08-17
US5932460A (en) 1999-08-03

Similar Documents

Publication Publication Date Title
NO955274L (no) Fremgangsmåte og anordning for forsegling av implanterbare membraninnkapslingsanordninger
CA2147626A1 (en) Cell Encapsulating Device
DE3469270D1 (en) Methods and apparatus for manufacture of valve flaps for cardiac valve prostheses
AU591967B2 (en) Mist cultivation of cells
WO1988006402A1 (en) Integument and method for culturing organic material
ATE41871T1 (de) Selbstschliessende subkutane einspritzstelle.
ATE157399T1 (de) In vivo sekretion von aktiven faktoren durch ko- kultivierte zellimplantate
IT1210493B (it) Composizioni che le contengono e proteine di membrana cellulare, procedimento per prepararle.
DK153122C (da) Lukke til engangsbrug til en kunstig eller inkontinent naturlig tarmaabning
AU2003206711A8 (en) Device for raising or cultivating cells in a container-like receptacle
ATE368385T1 (de) Molkereistarterkultur-abgabesystem und dessen verwendung
SE8201555L (sv) Sett att odla forankringsberoende celler
EP1462515A4 (en) DEVICE FOR CELL / TISSUE CULTURE
NO985628L (no) SÕrbandasje
ATE410054T1 (de) Durch elektroporation vermittelter molekulartransfer in intakten pflanzen
SE8105887L (sv) Blandning for human tillforsel av selen som sparemne
DE3266358D1 (en) Cell culture method
DE60026082D1 (de) Implantatsvorrichtung zum implantieren von zellkulturen
AU7577091A (en) Process for the artificial stimulation of cells and cyte culture device
CN118109293A (zh) 一种高通量小肠器官芯片仿生系统
JPS57192316A (en) Manufacture of assimilative respiration promoting low molecular substance for prevention, remedy and cell tissue cultivation
ATE215800T1 (de) Gewebeladesystem für implantierbare biologische vorrichtungen
ES2101694T3 (es) Expresion de edulcorantes proteinicos en levadura.
EP0174819A3 (en) Container
Merkur'eva et al. Experimental study of the function and enzyme organization of pulmonary alveolar macrophages in peroral nitrosodimethylamine exposure

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application